|
|
|
- さゆり かみこ
- 7 years ago
- Views:
Transcription
1 Focus
2
3 16-20 Open Up the Future ,000 1, ,257 4,338 5, , , % 26.0% 40% % Open Up the Future % 4, % % % % 3, % ,
4 1 10 4, , MT-5547 MT-6548 MT-5199 MT MT-2355 Hib ND STNM , % , % % % DPP-4 SGLT DPP-4 SGLT
5 BIKEN %1,894 63% , , MT-2271 VLP Virus Like ParticleMT VLP ND ,000 1,200 MT-2271 ND , MCI ALS ASEAN 2 2. ALS
6 ESG 2015 SDGs Sustainable Development Goals , , , ,158 2 RPA Robotic Process Automation MCHC KAITEKI MOS Management Of Sustainability Sustainability Health Comfort 3 MOS Health Health QOL SDGs KAITEKI MOS WEB MCHC
7 % 40.9% % 66.8% ESG IFRS50%
8 ,338 4, % % %
9 4 POC POC 1 MT-8554 MT-7117 POC MT-4129 MT-0814 MT
10 MT-1303 S1P MT-5547 NGF 2/3 2/3 MT POC MT-2990 ) 1 2 POC MT-6548 HIF-PH TA-7284 SGLT2 MT-3995 CREDENCE * * NASH CREDENCE MT-5199 VMAT2 2/3 2/ MT POC ND MT-1186 ALS 1 MT MT-2271 VLP
11 POC JOINUS in vitro 4 Stepping Up to the Future U.S.A
12 3 3 WEB URL CSR csr/report/consumer_issues/index.html
13 MT-5199 MT-5547 MT ALS MT-5199 MT-5547 MT MT-2355 MT-7117 MT-8554 POC MP
14 MR 2017 MT MCI-186 ALS TA MP-214 MP MCI-186 ALS MCI-186 ALS FTY720 FTY TA CANVAS / CANVAS-R MT MT
15 2017 3, AMP AMP % DPP-4 SGLT No.1 BIKEN PAF * * Platelet Activating Factor
16 AMP MR WEB URL CSR AMP csr/report/consumer_issues/information.html csr/report/consumer_issues/reliability.html Stepping Up to the Future MR MR 2010 MR * MR MR MR MR MR * MR
17 ,000 3,000 2,000 1, ,239 3,080 3, , , V IFRS 2015 IFRS
18 TNF TNF % %555 TNF TNF % %
19 2018 DPP %175 DPP % H OD % %
20 SSRI SSRI SAD %127 SSRI % SGLT T SGLT2SGLT SGLT %56 SGLT SGLT2 SGLT %
21 % No %49 BIKEN BIKEN BIKEN BIKENBIKEN % %
22 2017 DPP-4SGLT2 2 2 DPP-4 SGLT %32 PAF PAF PAF PAF DUAL
23 , PatientPhysician Payer 3P 3 1 2,000 2 MT-2271 ND ALS
24 ALS , ALS 3P ASEAN ALS ND0612 MT MTHA ,24011 ND VLP MT IT MTHA
25 VLP VLP VLP Virus-Like Particle VLP VLP VLP 5 6 VLP VLP VLP VLP MESSAGE VLP MT-2271 VLP VLP VLP VLP VLP CEO D
26 ND0612 ND ND ND MESSAGE CEO S
27 CMC CMC 2 1 CMC CMC
28 CMC WEB URL CSR ND0612 MT =../csr/report/consumer_issues/manufacturing.html MT-8554 MT-7117 MT
29 ASEAN 3 8% G1/G2 10 * 80%G180% G2 G1 6 G ,000 % % % 9, , , % Copyright 2018 IQVIA. IQVIA World Review Analyst Copyright 2018 IQVIA. IQVIA
30 * , , ,
31 16-20 OJT 1 Off-JT On the Job Training 2. Off the Job Training & LGBT 2017 LGBT LGBT LGBT ALLY MBO Management by Objective OJT Off-JT 4 OJT www28www: Win-Win Woman e LGBT 2* % 2017 MT-VIVID 2 OJT OJTO % 7.8% *
32 MCHC MCHC EHS URL WEB CSR MCHC KAITEKI KAITEKIMCHC WEB MTPC
33 Focus Employee Assistance Program * QOL 2017 i 2 Healthcare * i 2 HC i 2 HC MCHC PDCA i 2 HC 3 EAP
34 i 2 HCMCHC i 2 HC % 10 1,000 ALS i 2 HC MTPC % 6 9 5,000 ICT PDCA
KAITEKIレポート
INDEX R e p o r t Corporate Social Responsibility 1 2 2011 3 11 MCHC 616 26 6 MCHCGood Chemistry for Tomorrow APTSIS 10 20253 Sustainability Health Comfort 3 MBA Master of Business Administration MOT Management
小川／小川
p TRE p Mp p p M p S p p Tp M p p p p p p p p M T T T p p MT MR MR M M p p M M p p M T T T T T T T T S T M p M p T p M E M M p p p p TT T T p p p T T p T T T T T T T p p pt T T T p S T S S T p T T T T
SMBC Group Report 2018 CEO CEO SMBC Group Report 2018 1 SMBC 4 SMBC 6 7 ESG 10 SMBC 12 CEO 20 22 CFO 27 28 30 32 34 36 38 40 42 SMBC SMBC Group Report 2018 IIRC 2013 12 SMBC Group Report 2018 CSR 2017
02 CSR REPORT 09
02 CSR REPORT 09 CSR REPORT 09 03 04 CSR REPORT 09 CSR REPORT 09 05 06 CSR REPORT 09 REPORT 01 CSR REPORT 09 07 REPORT 02 08 CSR REPORT 09 REPORT 03 CSR REPORT 09 09 MESSAGE 10 CSR REPORT 09 MESSAGE CSR
- 2 -
- 2 - - 3 - - 4 - UJI - 5 - 50 22 3.5 3 50-6 - 60.5 45 10 2004 4 23 500 228-7 - 3 8-8 - - 9 - http://ranking.goo.ne.jp/ranking/011/antenna_shop/ - 10 - 14 4 17 10 90 17 48 66 ) ) - 11 - A () ) 291 2030
IF_SUPRECUR_N29
! @ # $ % ^ & * ( ) _ + )# ! a s d a s d f g h a s d @ a s d a s # a s d f g h j $ a s d f g h a s d % a s a a s a s a s d f g ^ a s a s a s & a s d f a s d f g h a s d f g a s d f g a s d a s d * s
スライド 1
2030 (2004) 1 2 3 1 212004 5.5203031 (1) 2004GDP () 2030GDP )1 2122005 21 2 ASEAN+5 3 207.3EU8.03.3 (2004) 4 10 22.8 16.11 121,006 100 593,369 100 19,715 16 247,813 42 34,217 28 88,772 15 6,832 6 43,746
OVERVIEW Our Sustainability ALSOK 1 ALSOK 1 P P.12 3 P.26 4 ALSOK 8 P.9
CSR REPORT 2013 CSR 2013 2331 OVERVIEW Our Sustainability ALSOK 1 ALSOK 1 P.10 2 7 2 P.12 3 P.26 4 ALSOK 8 P.9 ALSOK ALSOK CSR 5 P.8 6 6 P.19 7 3 4 P.18 5 8 P.20 ALSOK CSR Report 2013 1 OVERVIEW Our Corporate
1 z q w e r t y x c q w 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 R R 32 33 34 35 36 MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR
![.V...z.\](/thumbs/40/20575037.jpg ".V...z.\")
NTT COMWARE CORPORATION CSR REPORT 2018
NTT COMWARE CORPORATION CSR REPORT 2018 CSR マネジメント 私たちのアプローチ : 4つのコミュニケーション を実践し 安心 安全で豊かなコミュニケーション社会を実現 NTT CSR NTT CSR NTT NTT NTT CSR NTT NTT CSR NTT CSR CSR 4 CSR NTT CSR NTT CSR NTT CSR NTT CSR NTT2015
Sysmex_Report_2017
2017 2017 2016 4 1 2017 3 31 1-5-1 651-0073 Tel 078-265-0500 Fax 078-265-0524 www.sysmex.co.jp 1 2 Sysmex Report 2017 Sysmex Way Sysmex Way 5 13 55 76 31... 5 CEO... 13... 31 CSR... 57 10... 77... 7...
研究レポート表紙.PDF
No.131 April2002 44 1 7 1 2 1 8 45 1-1 2001 12 5.6 0.1 2001 0.3 5.0 12 337 1-2 1 13 20021 1 1 2001.7 2 3 2 3 20014 2 20014 1-1 1-3 6 2 4 1 2 3 3545 2002 1 11 2 1 80 23 1000 26 33 36 45 1000 51 64 41 51
2.8% 2.0% 2.4% 2.4% 0.4% 0.1% 0.3% 0.5% 3.8% 5.6% 25.6% 29.3% 64.6% 60.0% 1
2.8% 2.0% 2.4% 2.4% 0.4% 0.1% 0.3% 0.5% 3.8% 5.6% 25.6% 29.3% 64.6% 60.0% 1 16 24 21 20 20 23 10 11 9 10 3 3 3 2 3 1 3 4 6 8 2 0 1 2 3 4 5 6 0 1 2 3 4 5 6 0 1 2 3 4 5 6 3 4 Q & A Q1 A1 Q2 A2 Q3 A3 7
‡o‡P†C‡P‡Q”R„û†^‡P†C‡P‡Q
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, Q & A ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EPSON
B K L & & & & & & & & L & & & & & & & K & & & & & L L L & & & K L L L & & L L L & & & & & & & & & & & & & & & & & & & & & & & & & & & L & K L K & & & & & & & L L & & L & & L L & & & & &
bumon_pro.indd
q w e r t y u i o!0 !1!2!3 !4!5!6 !7!8!9 @0 @1 @2 @3 @4 @5 @6 @7 @8 @9 #0 #1 #2 #3 #4 #5 #6 #7 #8 #0 $0 $1 $2 $3 $4 $5 $6 $7 $8 $9 %0 %1 %2 %3 %4 %5 %6 %7 %8 %9 ^0 ^1 ^2 ^3 ^4 ^5 ^6 ^7 ^8 ^9 &0 &1 &2
2012_05_GLK_cover.indd
c %& r Z \ W W n q & F % % & & % & & % % % & % & % & % & % & % & F F % % % & & & & % & A
™…
2/10 15 2010. No1362 1 1 216315 91430 Q A & 0.23% 1 1.4% 04-7120-2020 050-5540-2023 Q A & 1 1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 1 2 3 4 5 6 7 8 9 10
untitled
1 2 3 4 () 5 6 7 8 9 10 2 22 3 11 12 13 2 1-14 1 4 1 18 4 1 4 () 15 16 17 18 19 20 21 () 26 2 22 23 24 26 2 25 26 27 1 NPO 28 29 30 - 1 31 32 33 34 35 1 36 37 - 38 26 2 39 26 2 40 41 61 42 43 44 45 3 6
,889 99, , , ,031 8,952 13,261 16,443 14,464 17,948 % ,037 8,848 10,927
2013 2013 3 3 313 31 2008 2009 2010 2011 2012 90,889 99,764 104,069 103,232 107,031 8,952 13,261 16,443 14,464 17,948 % 9.8 13.3 15.8 14.0 16.8 2,037 8,848 10,927 9,231 12,422 % 2.2 8.9 10.5 8.9 11.6 4,575
tomo_sp1
1....2 2....7...14 4....18 5....24 6....30 7....37 8....44...50 http://blog.garenet.com/tomo/ Copyright 2008 1. Copyright 2008 Copyright 2008 Copyright 2008 Copyright 2008 Copyright 2008 Copyright 2008
untitled
Copyright 3269 34 Copyright 3269 34 Copyright 3269 34 Copyright 3269 34 Copyright 3269 34 Copyright 3269 34 Copyright 3269 34 Copyright 3269 34 Copyright 3269 34 Copyright 3269 34 Copyright 3269 34 Copyright
2. (297) 91 (365) (366) (371) (673) (938) (64) 85 (91) (631) (561) (302) (616) 63 (906) 68 (338) (714) (747) (169) (718) 62 (1,063) 67 (714) (169) (90
1. (297) 91 (365) (366) (938) (371) (673) 68 (338) (473) (864) (396) (939) (217) (616) 89 (371) (673) (91) (938) (297) 82 (302) (938) (631) (297) (616) (91) 76 (203) 81 (561) (263) (64) (644) (616) 65
2. (1,009) 45 (368) (226) (133) (54) (260) 25 (446) 30 (774) (156) (805) (244) (652) 22 (128) (652) (157) (597) (805) (446) 30 (774) 35 (238) (581) (1
1. (189) 42 (133) (362) (93) (1,009) (260) (331) (189) (581) (238) (123) (140) (123) (362) (140) (238) (189) (581) (140) 41 (260) (93) (362) (1,009) (189) 21 (440) 26 (805) (597) (128) (446) (157) (362)
Microsoft Word - 教材ガイド一覧ビデオ.doc
V V V V V V V V V V V V 1 V V V V V V V V V V V V V V V V V V V V V V V V V V V V V V V V V V V V IT Web CG V V V V V V V V V V V V V V V V V V V V V V V V V V V V V V V V V V NO V V V V V
ABS STEP O/D OFF ABS 1 2 3 4 5 6 7 8 3 4 1 2 1 2 3 4 5 6 14 15 7 
ABS STEP O/D OFF ABS 1 2 3 4 5 6 7 8 4 5 1 2 3 1 宿泊産業活性化のための実証実験
121 32 10 12 12 19 2 15 59 40 33 34 35 36 37 38 3637 20 39 12 19 OFF 2008/12/19 2008/12/25 3 1 1 72,000 2008/12/19 2008/12/26 2 1 1 36,000 2008/12/28 2009/1/5 2 1 1 24,000 2009/1/6 2009/1/16 3 1 1 25,200
901 902 2 40 5 786 30 2 2 100 10100200 903 904 2 3 2 12 905 6765 30 3 61016 1 10162532 253240 2 2 1 2 100 24 45 545 1 2 2 510 1515 1010 50 300 0 10 2942 560 2 1 1 2 24 15 2565 2 10 2942 560 3 3 56 03 18
1037 1038 2 40 5 876 30 2 2 100 10100200 1039 1040 2 3 2 12 1041 6765 30 1 1 2 2 1 2 100 24 45 545 1 2 2 510 1515 1010 50 300 0 10 2942 560 2 1 3 2 10 2942 560 3 61016 1 10162532 253240 1 2 24 15 2565
<4D F736F F D B B BB2D834A836F815B82D082C88C60202D B2E646F63>
入社 5 年目までに身につけたい建設エンジニアの仕事術 サンプルページ この本の定価 判型などは, 以下の URL からご覧いただけます. http://www.morikita.co.jp/books/mid/087141 このサンプルページの内容は, 初版 1 刷発行当時のものです. i 3 5 2009 1 ii 1 1 1 2 3 3 6 13 1.1 14 1.2 15 1.3 17 1.4
PowerPoint プレゼンテーション
田辺三菱製薬株式会社 田辺三菱製薬株式会社事業説明会 2016 年 12 月 7 日 代表取締役社長三津家正之 アジェンダ 中期経営計画 16-20 概要 中期経営計画 16-20 2016 年度の成果 / 進捗 挑戦 1: パイプライン価値最大化 主なパイプラインと承認目標 注目パイプラインの状況 後期開発品 10 品目創製に向けた取り組み 挑戦 2: 育薬 営業強化 国内売上収益 3,000 億円